This research engineers immune T cells to better fight ovarian cancer. By modifying them to recognize tumor-specific proteins and resist cancer’s suppressive signals, the project strengthens the body’s natural defenses. The goal is to improve immunotherapy effectiveness, overcome tumor resistance, and increase survival rates for women facing this deadly disease.

This research develops an affordable, rapid genetic testing system to personalize antidepressant treatment. By detecting DNA mutations that affect drug metabolism, the technology helps doctors prescribe the right medication for each patient. The goal is to reduce ineffective treatments and improve mental health care—especially for veterans struggling with PTSD and depression.

This research investigates why blocking an early asthma “alarmin” signal often fails as a treatment. Using mouse models, it reveals that environmental differences—particularly the microbiome—can bypass this signal and still drive asthma. Understanding microbiome health may help predict treatment success and lead to more personalized, effective asthma therapies.

Malnutrition is a major but often overlooked cause of mortality in cancer patients, driven by the side effects of aggressive treatments. This research focuses on personalized nutritional care, combining medical data with patient experiences to improve strength, quality of life, and treatment tolerance—because without nutrition, effective cancer therapy is impossible.

A researcher explains how anatomical differences in the vagus nerve drive inconsistent outcomes in epilepsy treatment. By dissecting and 3D-mapping human vagus nerves, the team reveals major left–right differences, enabling more precise electrode placement. This work promises safer, more effective nerve stimulation therapies for epilepsy and other diseases.

This research shows that genetic risk scores alone are insufficient for predicting chronic disease. By incorporating social and environmental factors using machine learning, disease prediction improves substantially, especially for disadvantaged populations. Integrating genetic and social risk is essential for equitable, effective personalized medicine.

This research explores motor imagery as a rehabilitation tool after stroke. Brain imaging revealed sex-based differences in neural activation, with females showing greater efficiency. Practice improves patterns in both sexes. Understanding these differences enables personalized, home-based rehabilitation that may enhance recovery of arm and hand function.

Migraine affects over 10% of people and disproportionately impacts women. This research studies sex differences in brain circuits using mouse models to understand why. By manipulating neural pathways, findings show certain circuits trigger migraine-like sensitivity only in females. Mapping these circuits may enable personalized, more effective migraine treatments.